Surgical pulmonary arterioplasty at bidirectional cavopulmonary anastomosis leads to favorable pulmonary hemodynamics at final stage palliation

Anna Olds MD , W. Hampton Gray MD , Markian Bojko MD , Carly Weaver BA , John D. Cleveland MD , Michael E. Bowdish MD, MS , Winfield J. Wells MD , Vaughn A. Starnes MD , S. Ram Kumar MD, PhD, FACS
{"title":"Surgical pulmonary arterioplasty at bidirectional cavopulmonary anastomosis leads to favorable pulmonary hemodynamics at final stage palliation","authors":"Anna Olds MD ,&nbsp;W. Hampton Gray MD ,&nbsp;Markian Bojko MD ,&nbsp;Carly Weaver BA ,&nbsp;John D. Cleveland MD ,&nbsp;Michael E. Bowdish MD, MS ,&nbsp;Winfield J. Wells MD ,&nbsp;Vaughn A. Starnes MD ,&nbsp;S. Ram Kumar MD, PhD, FACS","doi":"10.1016/j.xjon.2024.02.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Pulmonary arterioplasty (PA plasty) at bidirectional cavopulmonary anastomosis (BDCA) is associated with increased morbidity, but outcomes to final stage palliation are unknown. We sought to determine the influence of PA plasty on pulmonary artery growth and hemodyamics at Fontan.</p></div><div><h3>Methods</h3><p>We retrospectively reviewed clinical data and outcomes for BDCA patients from 2006 to 2018. PA plasty was categorized by extent (type 1-4), as previously described. Outcomes included pulmonary artery reintervention and mortality before final palliation.</p></div><div><h3>Results</h3><p>Five hundred eighty-eight patients underwent BDCA. One hundred seventy-nine patients (30.0%) underwent concomitant PA plasty. Five hundred seventy (97%) patients (169 [94%] PA plasty) survived to BDCA discharge. One hundred forty out of 570 survivors (25%) required PA/Glenn reintervention before final stage palliation (59 out of 169 [35%]) PA plasty; 81 out of 401 (20%) non-PA plasty; <em>P</em> &lt; .001). Twelve-, 24-, and 36-month freedom from reintervention after BDCA was 80% (95% CI, 74-86%), 75% (95% CI, 69-82%), and 64% (95% CI, 57-73%) for PA plasty, and 95% (95% CI, 93-97%), 91% (95% CI, 88-94%), and 81% (95% CI, 76-85%) for non-PA plasty (<em>P</em> &lt; .001). Prefinal stage mortality was 37 (6.3%) (14 out of 169 PA plasty; 23 out of 401 non-PA plasty; <em>P</em> = .4). Five hundred four (144 PA plasty and 360 non-PA plasty) patients reached final stage palliation (471 Fontan, 26 1.5-ventricle, and 7 2-ventricular repair). Pre-Fontan PA pressure and pulmonary vascular resistance were 10 mm Hg (range, 9-12 mm Hg) and 1.6 mm Hg (range, 1.3-1.9 mm Hg) in PA plasty and 10 mm Hg (range, 8-12 mm Hg) and 1.5 mm Hg (range, 1.3-1.9 mm Hg) in non-PA plasty patients, respectively (<em>P</em> = .29, .6). Fontan hospital mortality, length of stay, and morbidity were similar.</p></div><div><h3>Conclusions</h3><p>PA plasty at BDCA does not confer additional mortality risk leading to final palliation. Despite increased pulmonary artery reintervention, there was reliable pulmonary artery growth and favorable pulmonary hemodynamics at final stage palliation.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266627362400041X/pdfft?md5=f028be2da1002b423527a6138272e2a1&pid=1-s2.0-S266627362400041X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTCVS open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266627362400041X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Pulmonary arterioplasty (PA plasty) at bidirectional cavopulmonary anastomosis (BDCA) is associated with increased morbidity, but outcomes to final stage palliation are unknown. We sought to determine the influence of PA plasty on pulmonary artery growth and hemodyamics at Fontan.

Methods

We retrospectively reviewed clinical data and outcomes for BDCA patients from 2006 to 2018. PA plasty was categorized by extent (type 1-4), as previously described. Outcomes included pulmonary artery reintervention and mortality before final palliation.

Results

Five hundred eighty-eight patients underwent BDCA. One hundred seventy-nine patients (30.0%) underwent concomitant PA plasty. Five hundred seventy (97%) patients (169 [94%] PA plasty) survived to BDCA discharge. One hundred forty out of 570 survivors (25%) required PA/Glenn reintervention before final stage palliation (59 out of 169 [35%]) PA plasty; 81 out of 401 (20%) non-PA plasty; P < .001). Twelve-, 24-, and 36-month freedom from reintervention after BDCA was 80% (95% CI, 74-86%), 75% (95% CI, 69-82%), and 64% (95% CI, 57-73%) for PA plasty, and 95% (95% CI, 93-97%), 91% (95% CI, 88-94%), and 81% (95% CI, 76-85%) for non-PA plasty (P < .001). Prefinal stage mortality was 37 (6.3%) (14 out of 169 PA plasty; 23 out of 401 non-PA plasty; P = .4). Five hundred four (144 PA plasty and 360 non-PA plasty) patients reached final stage palliation (471 Fontan, 26 1.5-ventricle, and 7 2-ventricular repair). Pre-Fontan PA pressure and pulmonary vascular resistance were 10 mm Hg (range, 9-12 mm Hg) and 1.6 mm Hg (range, 1.3-1.9 mm Hg) in PA plasty and 10 mm Hg (range, 8-12 mm Hg) and 1.5 mm Hg (range, 1.3-1.9 mm Hg) in non-PA plasty patients, respectively (P = .29, .6). Fontan hospital mortality, length of stay, and morbidity were similar.

Conclusions

PA plasty at BDCA does not confer additional mortality risk leading to final palliation. Despite increased pulmonary artery reintervention, there was reliable pulmonary artery growth and favorable pulmonary hemodynamics at final stage palliation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在双向腔肺吻合处进行肺动脉成形术,可在最后阶段的姑息治疗中获得良好的肺血流动力学效果
目的双向腔肺吻合术(BDCA)中的肺动脉成形术(PA plasty)与发病率增加有关,但最终阶段的缓解结果尚不清楚。我们试图确定PA成形术对Fontan时肺动脉生长和血液动力学的影响。方法我们回顾性地回顾了2006年至2018年BDCA患者的临床数据和结果。如前所述,PA成形术按程度分类(1-4型)。结果包括肺动脉再介入和最终缓解前的死亡率。179名患者(30.0%)同时进行了PA成形术。570例(97%)患者(169例[94%] PA成形术)存活至BDCA出院。570名幸存者中有140人(25%)在最后阶段缓解前需要进行PA/Glenn再介入治疗(169人中有59人[35%]接受了PA成形术;401人中有81人(20%)未接受PA成形术;P <.001)。BDCA术后12个月、24个月和36个月的再干预自由度分别为:PA成形术为80%(95% CI,74-86%)、75%(95% CI,69-82%)和64%(95% CI,57-73%);非PA成形术为95%(95% CI,93-97%)、91%(95% CI,88-94%)和81%(95% CI,76-85%)(P < .001)。终末期前死亡率为 37 例(6.3%)(169 例 PA 成形术中有 14 例;401 例非 PA 成形术中有 23 例;P = .4)。54名(144名PA成形术患者和360名非PA成形术患者)患者达到最终阶段缓解(471名Fontan患者、26名1.5心室患者和7名2心室修复患者)。PA成形术患者的Fontan前PA压力和肺血管阻力分别为10毫米汞柱(范围为9-12毫米汞柱)和1.6毫米汞柱(范围为1.3-1.9毫米汞柱),非PA成形术患者的PA压力和肺血管阻力分别为10毫米汞柱(范围为8-12毫米汞柱)和1.5毫米汞柱(范围为1.3-1.9毫米汞柱)(P = .29, .6)。Fontan住院死亡率、住院时间和发病率相似。尽管肺动脉再介入增加了,但在最终缓解阶段,肺动脉生长可靠,肺血流动力学良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
0
期刊最新文献
Discussion to: Salvage lung resection after immunotherapy is feasible and safe Salvage lung resection after immunotherapy is feasible and safe Identifying Asian American lung cancer disparities: A novel analytic approach Discussion to: Identifying lung cancer disparities among Asian Americans: A novel analytic approach Risk factors for thromboembolic events in pediatric patients with ventricular assist devices
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1